Junchan personal page - To The Moon

Junchan

No personal profile

1Follow

2Followers

0Topic

0Badge

2022-11-18

Ok

Sorry, the original content has been removed

2021-12-17

Ok

2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.

2021-06-29

Like pls

Sorry, the original content has been removed

2021-06-28

Like pls

Sorry, the original content has been removed

2021-06-27

Comment and like pls

Sorry, the original content has been removed

2021-06-26

Hope it breaks 700 again

Sorry, the original content has been removed

2021-06-25

Comment

Sorry, the original content has been removed

2021-06-24

Comment and like

Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.

2021-06-23

Ok

Sorry, the original content has been removed

2021-06-22

Comment and like

Sorry, the original content has been removed

2021-06-21

Like please

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3582060962041245,"uuid":"3582060962041245","gmtCreate":1618968949065,"gmtModify":1618968949065,"name":"Junchan","pinyin":"junchan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":1,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9961018610,"gmtCreate":1668784710531,"gmtModify":1676538113738,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":14,"repostSize":0,"link":"https://ttm.financial/post/9961018610","repostId":"1180793927","repostType":4,"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000983862,"gmtCreate":1639727296662,"gmtModify":1676533493217,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":251,"repostSize":0,"link":"https://ttm.financial/post/9000983862","repostId":"1131183374","repostType":4,"repost":{"id":"1131183374","pubTimestamp":1639724439,"share":"https://www.laohu8.com/m/news/1131183374?lang=&edition=full","pubTime":"2021-12-17 15:00","market":"us","language":"en","title":"2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.","url":"https://stock-news.laohu8.com/highlight/detail?id=1131183374","media":"Barrons","summary":"The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly","content":"<p>The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.</p>\n<p>Immix (ticker: IMMX) is the third company this week to trade below its initial public offering price. On Wednesday, Genenta Science (GNTA), a biotech, fell more than 4%, while Fresh Vine Wine (VINE), a producer of low-carb wine, plunged nearly 30% the day before.</p>\n<p>Bionomics (BNOX) also opened on Thursday, with shares rising more than 19%. The biotech is not considered an IPO since its stock already trades on the Australian Securities Exchange.</p>\n<p>IPOs have slowed considerably in December. Ten companies have gone public this month in traditional IPOs, raising $4.9 billion, Dealogic said. This compares to last year, when 21 companies listed their shares using traditional offerings, collecting $12.8 billion.</p>\n<p>The IPO market is expected to go on break next week for the holidays, with many deals going on hold. New issues are expected to reopen in mid-January. No companies are expected to go public on Friday using a traditional offering.</p>\n<p>Six companies, including Immix and Bionomics, have priced their deals this week. Sidus Space (SIDU), a satellite company, turned in a strong performance when its stock rocketed nearly 144% Tuesday. On Wednesday, the stock of Samsara (IOT), an internet of things company, rose more than 7%.</p>\n<p>Shares of Immix opened at $5 and dropped. The stock closed at $3.67, down $1.33 from its offer price.</p>\n<p>Immix is developing tissue-specific therapeutics to treat cancer and inflammation. Its lead product candidate, IMX-110, is currently in Phase 1b/2a clinical trials for solid tumors in the United States and Australia, a prospectus said.</p>\n<p>Immix increased the size of its deal to $4.2 million shares, which it sold at $5 each. The Los Angeles company had planned on selling roughly 3.83 million shares at $5 to $6 each.</p>\n<p>Shares of Bionomcis, meanwhile, opened at $22 and ended at $14.73, up $2.38 cents from its offer price.</p>\n<p>Bionomics is developing therapies for persons suffering from serious central nervous system disorders. Its lead product candidate, BNC210, treats social anxiety disorder and post-traumatic stress disorder, according to a prospectus.</p>\n<p>Bionomics sold 1.62 million American Depositary Shares, or ADSs, at $12.35 a share. Each ADS represents 180 ordinary shares of Bionomics.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.\nImmix (ticker: IMMX) is the third company this week to trade below its ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IMMX":"Immix Biopharma, Inc","BNOX":"Bionomics Limited"},"source_url":"https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1131183374","content_text":"The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.\nImmix (ticker: IMMX) is the third company this week to trade below its initial public offering price. On Wednesday, Genenta Science (GNTA), a biotech, fell more than 4%, while Fresh Vine Wine (VINE), a producer of low-carb wine, plunged nearly 30% the day before.\nBionomics (BNOX) also opened on Thursday, with shares rising more than 19%. The biotech is not considered an IPO since its stock already trades on the Australian Securities Exchange.\nIPOs have slowed considerably in December. Ten companies have gone public this month in traditional IPOs, raising $4.9 billion, Dealogic said. This compares to last year, when 21 companies listed their shares using traditional offerings, collecting $12.8 billion.\nThe IPO market is expected to go on break next week for the holidays, with many deals going on hold. New issues are expected to reopen in mid-January. No companies are expected to go public on Friday using a traditional offering.\nSix companies, including Immix and Bionomics, have priced their deals this week. Sidus Space (SIDU), a satellite company, turned in a strong performance when its stock rocketed nearly 144% Tuesday. On Wednesday, the stock of Samsara (IOT), an internet of things company, rose more than 7%.\nShares of Immix opened at $5 and dropped. The stock closed at $3.67, down $1.33 from its offer price.\nImmix is developing tissue-specific therapeutics to treat cancer and inflammation. Its lead product candidate, IMX-110, is currently in Phase 1b/2a clinical trials for solid tumors in the United States and Australia, a prospectus said.\nImmix increased the size of its deal to $4.2 million shares, which it sold at $5 each. The Los Angeles company had planned on selling roughly 3.83 million shares at $5 to $6 each.\nShares of Bionomcis, meanwhile, opened at $22 and ended at $14.73, up $2.38 cents from its offer price.\nBionomics is developing therapies for persons suffering from serious central nervous system disorders. Its lead product candidate, BNC210, treats social anxiety disorder and post-traumatic stress disorder, according to a prospectus.\nBionomics sold 1.62 million American Depositary Shares, or ADSs, at $12.35 a share. Each ADS represents 180 ordinary shares of Bionomics.","news_type":1},"isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159070940,"gmtCreate":1624933228880,"gmtModify":1703848267831,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":176,"repostSize":0,"link":"https://ttm.financial/post/159070940","repostId":"1195734655","repostType":4,"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127841623,"gmtCreate":1624844268862,"gmtModify":1703845960818,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":24,"repostSize":0,"link":"https://ttm.financial/post/127841623","repostId":"1157825898","repostType":4,"isVote":1,"tweetType":1,"viewCount":654,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124853891,"gmtCreate":1624759502613,"gmtModify":1703844543178,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like pls","listText":"Comment and like pls","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/124853891","repostId":"2146070550","repostType":4,"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125679385,"gmtCreate":1624673163447,"gmtModify":1703843302817,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hope it breaks 700 again&nbsp;","listText":"Hope it breaks 700 again&nbsp;","text":"Hope it breaks 700 again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/125679385","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126779446,"gmtCreate":1624586273985,"gmtModify":1703841025806,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/126779446","repostId":"1144285047","repostType":4,"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128327954,"gmtCreate":1624502778478,"gmtModify":1703838582425,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like&nbsp;","listText":"Comment and like&nbsp;","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/128327954","repostId":"1105753491","repostType":4,"repost":{"id":"1105753491","pubTimestamp":1624501994,"share":"https://www.laohu8.com/m/news/1105753491?lang=&edition=full","pubTime":"2021-06-24 10:33","market":"us","language":"en","title":"Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=1105753491","media":"Benzinga","summary":"Canopy Growth Corporation(TSX:WEED) (NASDAQ:CGC) has merged withThe Supreme Cannabis Company, Inc.(T","content":"<p><b>Canopy Growth Corporation</b>(TSX:WEED) (NASDAQ:CGC) has merged with<b>The Supreme Cannabis Company, Inc.</b>(TSX:FIRE) (OTCQX:SPRWF), wrapping up their&nbsp;previously announceddeal on Wednesday.</p>\n<p><b>Transaction Details:</b>Canopy acquired all of the issued and outstanding common shares of Supreme, which became a wholly-owned subsidiary of Canopy.</p>\n<p>In return, Supreme shareholders will receive 0.01165872 of a common share of Canopy and $0.0001 in cash for each Supreme share held.</p>\n<p>Under the terms of the agreement, Canopy issued roughly 9,013,400 shares and paid around $84,096.89 in cash in exchange for Supreme shares.</p>\n<p>To obtain shares of Canopy, shareholders of Supreme are required to complete, sign, date&nbsp;and return the letter of transmittal, previously emailed to each Supreme shareholder prior to closing.</p>\n<p>Cassels Brock &amp; Blackwell LLP acted as strategic and legal counsel to Canopy for the transaction.</p>\n<p>BMO Capital Markets acted as financial advisor to Supreme, while Borden Ladner Gervais LLP served as legal counsel. Kingsdale Advisors acted as strategic shareholder advisor and proxy solicitation agent to Supreme.</p>\n<p><b>What It Means For Canopy:</b>David Klein, CEO of Canopy, said the acquisition of Supreme strengthens the company’s “leadership position by offering Canadian consumers a differentiated brand portfolio – including the addition of 7ACRES, which further bolsters our premium product segment.”&nbsp;Canopy is located in Smiths Falls, Ontario.</p>\n<p>The merger brings 7ACRES&nbsp;and 7ACRES Craft Collective brands as well as Supreme’s Kincardine, an&nbsp;Ontario-based&nbsp;cultivation facility,&nbsp;under Canopy's&nbsp;helm, creating a pro forma fourth quarter 2021 market share of 18.1%.</p>\n<p>“Supreme has demonstrated the ability to cultivate premium quality cannabis flower at low cost, and we’re excited to leverage these capabilities to further our leadership in the Canadian market as we scale these newly added brands and accelerate revenue growth,” Klein added.</p>\n<p>Beena Goldenberg, CEO of Supreme, said joining Canopy is \"aligned with our ultimate goal of becoming a premier cannabis CPG company.\" She called&nbsp;the acquisition “the best path forward for Supreme’s shareholders to generate long-term value.”</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 10:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/06/21686949/cannabis-mergers-canopy-growth-issues-9-million-shares-to-complete-acquisition-of-supreme-cannab><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth Corporation(TSX:WEED) (NASDAQ:CGC) has merged withThe Supreme Cannabis Company, Inc.(TSX:FIRE) (OTCQX:SPRWF), wrapping up their previously announceddeal on Wednesday.\nTransaction Details...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/06/21686949/cannabis-mergers-canopy-growth-issues-9-million-shares-to-complete-acquisition-of-supreme-cannab\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGC":"Canopy Growth Corporation"},"source_url":"https://www.benzinga.com/markets/cannabis/21/06/21686949/cannabis-mergers-canopy-growth-issues-9-million-shares-to-complete-acquisition-of-supreme-cannab","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105753491","content_text":"Canopy Growth Corporation(TSX:WEED) (NASDAQ:CGC) has merged withThe Supreme Cannabis Company, Inc.(TSX:FIRE) (OTCQX:SPRWF), wrapping up their previously announceddeal on Wednesday.\nTransaction Details:Canopy acquired all of the issued and outstanding common shares of Supreme, which became a wholly-owned subsidiary of Canopy.\nIn return, Supreme shareholders will receive 0.01165872 of a common share of Canopy and $0.0001 in cash for each Supreme share held.\nUnder the terms of the agreement, Canopy issued roughly 9,013,400 shares and paid around $84,096.89 in cash in exchange for Supreme shares.\nTo obtain shares of Canopy, shareholders of Supreme are required to complete, sign, date and return the letter of transmittal, previously emailed to each Supreme shareholder prior to closing.\nCassels Brock & Blackwell LLP acted as strategic and legal counsel to Canopy for the transaction.\nBMO Capital Markets acted as financial advisor to Supreme, while Borden Ladner Gervais LLP served as legal counsel. Kingsdale Advisors acted as strategic shareholder advisor and proxy solicitation agent to Supreme.\nWhat It Means For Canopy:David Klein, CEO of Canopy, said the acquisition of Supreme strengthens the company’s “leadership position by offering Canadian consumers a differentiated brand portfolio – including the addition of 7ACRES, which further bolsters our premium product segment.” Canopy is located in Smiths Falls, Ontario.\nThe merger brings 7ACRES and 7ACRES Craft Collective brands as well as Supreme’s Kincardine, an Ontario-based cultivation facility, under Canopy's helm, creating a pro forma fourth quarter 2021 market share of 18.1%.\n“Supreme has demonstrated the ability to cultivate premium quality cannabis flower at low cost, and we’re excited to leverage these capabilities to further our leadership in the Canadian market as we scale these newly added brands and accelerate revenue growth,” Klein added.\nBeena Goldenberg, CEO of Supreme, said joining Canopy is \"aligned with our ultimate goal of becoming a premier cannabis CPG company.\" She called the acquisition “the best path forward for Supreme’s shareholders to generate long-term value.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123801467,"gmtCreate":1624414190859,"gmtModify":1703835946864,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/123801467","repostId":"1115637073","repostType":4,"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120678623,"gmtCreate":1624323165762,"gmtModify":1703833392488,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120678623","repostId":"2145352630","repostType":4,"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167051094,"gmtCreate":1624240353718,"gmtModify":1703831263560,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/167051094","repostId":"1182485162","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9000983862,"gmtCreate":1639727296662,"gmtModify":1676533493217,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":251,"repostSize":0,"link":"https://ttm.financial/post/9000983862","repostId":"1131183374","repostType":4,"isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159070940,"gmtCreate":1624933228880,"gmtModify":1703848267831,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":176,"repostSize":0,"link":"https://ttm.financial/post/159070940","repostId":"1195734655","repostType":4,"repost":{"id":"1195734655","pubTimestamp":1624932851,"share":"https://www.laohu8.com/m/news/1195734655?lang=&edition=full","pubTime":"2021-06-29 10:14","market":"us","language":"en","title":"NIO Will Surpass Tesla as China's Top EV Maker, Navellier Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1195734655","media":"thestreet","summary":"NIO (NIO) -Get Report shares rose Monday after Louis Navellier, chief investment officer of money ma","content":"<p>NIO&nbsp;(<b>NIO</b>) -Get Report&nbsp;shares rose Monday after Louis Navellier, chief investment officer of money manager Navellier, said the Chinese electric-car maker will surpass Tesla&nbsp;(<b>TSLA</b>) -Get Report&nbsp;in China.</p>\n<p>“Another electric vehicle company will eventually displace Tesla as the biggest manufacturer of EVs in China,” he wrote in a commentary.</p>\n<p>“I’m talking about NIO. The reality is that this company is on the verge of dominating the EV market in China and Hong Kong.”</p>\n<p>NIO American depositary receipts recently traded at $49.23, up 9.2%. They have climbed 27% in the past month amid investor enthusiasm for EVs.</p>\n<p>Tesla recently traded at $687.47, up 2.3%, and has gained 9% in the past month.</p>\n<p>As for NIO, “the company boasts that it is the ‘next-generation car company,’ as it designs and manufactures electric vehicles that utilize the latest technologies in connectivity, autonomous driving and artificial intelligence,” Navellier said.</p>\n<p>“The company is also partnering with cutting-edge chip companies like Nvidia&nbsp;(<b>NVDA</b>) -Get Report.”</p>\n<p>Earlier this month,NIO said that \"Gemini\" was the code namefor a new high-end electric-vehicle lineup to be launched next year. The move buried speculation that the Shanghai EV maker was looking to release a less-expensive mass-entry-level electric car.</p>\n<p>NIO supplier JAC Group last month invited bids to build a NIO production line code-named “Gemini” that would produce 60,000 units a year. That sparked speculation that it would be a new entry-level NIO model.</p>\n<p>Also in June,NIO reported a more than 95% year-over-year increasein deliveries for May. Citi analyst Jeff Chung upgraded the stock to buy from neutral while raising his price target to $58.30 from $57.60.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Will Surpass Tesla as China's Top EV Maker, Navellier Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Will Surpass Tesla as China's Top EV Maker, Navellier Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 10:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/nio-to-surpass-tesla-in-china-electric-vehicles-navellier-says><strong>thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NIO (NIO) -Get Report shares rose Monday after Louis Navellier, chief investment officer of money manager Navellier, said the Chinese electric-car maker will surpass Tesla (TSLA) -Get Report in China....</p>\n\n<a href=\"https://www.thestreet.com/investing/nio-to-surpass-tesla-in-china-electric-vehicles-navellier-says\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/investing/nio-to-surpass-tesla-in-china-electric-vehicles-navellier-says","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195734655","content_text":"NIO (NIO) -Get Report shares rose Monday after Louis Navellier, chief investment officer of money manager Navellier, said the Chinese electric-car maker will surpass Tesla (TSLA) -Get Report in China.\n“Another electric vehicle company will eventually displace Tesla as the biggest manufacturer of EVs in China,” he wrote in a commentary.\n“I’m talking about NIO. The reality is that this company is on the verge of dominating the EV market in China and Hong Kong.”\nNIO American depositary receipts recently traded at $49.23, up 9.2%. They have climbed 27% in the past month amid investor enthusiasm for EVs.\nTesla recently traded at $687.47, up 2.3%, and has gained 9% in the past month.\nAs for NIO, “the company boasts that it is the ‘next-generation car company,’ as it designs and manufactures electric vehicles that utilize the latest technologies in connectivity, autonomous driving and artificial intelligence,” Navellier said.\n“The company is also partnering with cutting-edge chip companies like Nvidia (NVDA) -Get Report.”\nEarlier this month,NIO said that \"Gemini\" was the code namefor a new high-end electric-vehicle lineup to be launched next year. The move buried speculation that the Shanghai EV maker was looking to release a less-expensive mass-entry-level electric car.\nNIO supplier JAC Group last month invited bids to build a NIO production line code-named “Gemini” that would produce 60,000 units a year. That sparked speculation that it would be a new entry-level NIO model.\nAlso in June,NIO reported a more than 95% year-over-year increasein deliveries for May. Citi analyst Jeff Chung upgraded the stock to buy from neutral while raising his price target to $58.30 from $57.60.","news_type":1},"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127841623,"gmtCreate":1624844268862,"gmtModify":1703845960818,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":24,"repostSize":0,"link":"https://ttm.financial/post/127841623","repostId":"1157825898","repostType":4,"isVote":1,"tweetType":1,"viewCount":654,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9961018610,"gmtCreate":1668784710531,"gmtModify":1676538113738,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":14,"repostSize":0,"link":"https://ttm.financial/post/9961018610","repostId":"1180793927","repostType":4,"repost":{"id":"1180793927","pubTimestamp":1668783664,"share":"https://www.laohu8.com/m/news/1180793927?lang=&edition=full","pubTime":"2022-11-18 23:01","market":"us","language":"en","title":"Top Calls on Wall Street: Amazon, HP, DraftKings, Applied Materials and More","url":"https://stock-news.laohu8.com/highlight/detail?id=1180793927","media":"The Fly","summary":"Top 5 Upgrades:JPMorgan analyst Lisa Gill upgraded Walgreens Boots Alliance(WBA) to Overweight from ","content":"<html><head></head><body><h2><b>Top 5 Upgrades:</b></h2><ul><li>JPMorgan analyst Lisa Gill upgraded <b>Walgreens Boots Alliance</b>(WBA) to Overweight from Neutral with a $42 price target. The company has &#34;significantly invested in its transformational consumer-centric healthcare strategy,&#34; the centerpiece of which is the launch of Walgreens Healthcare, Gill tells investors.</li><li>Summit Insights analyst Kinngai Chan upgraded <b>Applied Materials</b>(AMAT) to Buy from Hold post the October quarter results. The analyst now believes the 2023 wafer dab spending cuts are priced into the stock.</li><li>Gordon Haskett analyst Chuck Grom upgraded <b>Ross Stores</b>(ROST) to Buy from Hold with a $130 price target. He had turned incrementally more positive on the off-price retail space last week when he&#39;d upgraded TJX (TJX) to Buy, but the results from Ross and across the space with over 10 companies under coverage reporting Q3 results this week lead him to see more &#34;evidence&#34; that middle-income shoppers would begin to trade down into the off-price space.</li><li>Guggenheim analyst Shahriar Pourreza upgraded <b>Pinnacle West</b>(PNW) to Neutral from Sell with a price target of $70, up from $54. The regulatory construct in Arizona has improved following the election loss of Commissioner Sandra Kennedy and the victories of two Republican commissioners, Pourreza tells investors.</li><li>Northcoast analyst Jim Sanderson upgraded <b>Domino&#39;s Pizza</b>(DPZ) to Buy from Neutral with a $460 price target.</li></ul><h2><b>Top 5 Downgrades:</b></h2><ul><li>Credit Suisse analyst Shannon Cross downgraded <b>HP Inc.</b>(HPQ) to Neutral from Outperform with an unchanged price target of $33. The analyst believes the company&#39;s revenue and margins will be &#34;challenged near term&#34; by weakening consumer sentiment, pressure on selling prices as a result of lower demand and better supply, slower enterprise demand near term for PCs and printing as IT budgets prioritize hybrid cloud, security and software solutions, and macroeconomic uncertainty.</li><li>Oppenheimer analyst Jay Olson downgraded <b>Editas Medicine</b>(EDIT) to Perform from Outperform with a price target of $12, down from $28. The downgrade follows the announcement that the Phase 1/2 BRILLIANCE trial of EDIT-101 for Leber congenital amaurosis 10 is pausing enrollment following preliminary efficacy data that showed only three of the 14 patients met the responder threshold of clinically meaningful improvement in best corrected visual acuity, Olson tells investors in a research note. Credit Suisse analyst Tiago Fauth also downgraded Editas Medicine to Neutral from Outperform with a price target of $13, down from $25, after removing the contribution from EDIT-101 and other ocular indications from his model following the company&#39;s update from the BRILLIANCE trial.</li><li>Morgan Stanley analyst Lauren Schenk downgraded <b>Rent The Runway</b>(RENT) to Equal Weight from Overweight with a price target of $2.50, down from $10. Recent web traffic data suggests a &#34;meaningful October slowdown&#34; and a Q3 subscriber miss after an encouraging September, Schenk tells investors in a research note.</li><li>Wedbush analyst Seth Basham downgraded <b>RH</b>(RH) to Neutral from Outperform with a price target of $270, down from $274. RH has been steadfast in protecting its brand without discounting, but this has contributed to mounting market share losses, Basham tells investors in a research note.</li><li>Erste Group analyst Hans Engel downgraded <b>Amazon.com</b>(AMZN) to Hold from Buy. The &#34;outlook for earnings development has deteriorated in recent weeks,&#34; Engel tells investors.</li></ul><h2><b>Top 5 Initiations:</b></h2><ul><li>Piper Sandler analyst Matt Farrell initiated coverage of <b>DraftKings</b>(DKNG) with an Overweight rating and $21 price target. DraftKings is a leader in the online sports betting market with a growing presence in internet gaming, which combined represent an $80B total addressable market between the United States and Canada, Farrell tells investors in a research note.</li><li>Credit Suisse analyst Trung Huynh initiated coverage of <b>Merck</b>(MRK) with an Outperform rating and $120 price target, calling it one of his two top ideas based on a relative basis among the U.S. large-cap biopharma peer group. He sees Merck having &#34;low-risk and high short-term growth&#34; as he sees Keytruda growing at over 20% year-over-year, giving the company &#34;ample time&#34; to fill its loss-of-exclusivity cliff by end-2028.</li><li>Raymond James analyst Andrew Cooper initiated coverage of <b>Fulgent Genetics</b>(FLGT) with an Outperform rating and $45 price target. The company capitalized on COVID-19 testing capabilities and has now deployed part of its &#34;substantial cash hoard&#34; to emerge from the pandemic with the full breadth of oncology testing capabilities, Cooper tells investors in a research note.</li><li>BofA analyst Jason Zemansky initiated coverage of <b>Insmed</b>(INSM) with a Buy rating and $39 price target. The company&#39;s differentiated pipeline and strong underlying fundamentals place it apart from its peers, presenting a &#34;compelling&#34; risk-reward, the analyst tells investors in a research note.</li><li>Morgan Stanley analyst Alex Straton assumed coverage of <b>Ross Stores</b> with an Overweight rating with a price target of $127, up from $119, following the company&#39;s Q3 report. The magnitude of the Q3 beat &#34;surprised to the upside&#34; and revenue re-acceleration &#34;makes for a compelling set-up&#34; into Q4 and 2023, said Straton, who thinks &#34;things only get better from here.&#34;</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Calls on Wall Street: Amazon, HP, DraftKings, Applied Materials and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Calls on Wall Street: Amazon, HP, DraftKings, Applied Materials and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-18 23:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/landingPageNews.php?id=3621141&headline=HPQ;DKNG;EDIT;RENT;MRK;RH;FLGT;WBA;AMAT;ROST;TJX;PNW;DPZ;AMZN;INSM-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:JPMorgan analyst Lisa Gill upgraded Walgreens Boots Alliance(WBA) to Overweight from Neutral with a $42 price target. The company has \"significantly invested in its transformational ...</p>\n\n<a href=\"https://thefly.com/landingPageNews.php?id=3621141&headline=HPQ;DKNG;EDIT;RENT;MRK;RH;FLGT;WBA;AMAT;ROST;TJX;PNW;DPZ;AMZN;INSM-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HPQ":"惠普","AMAT":"应用材料","AMZN":"亚马逊","DKNG":"DraftKings Inc."},"source_url":"https://thefly.com/landingPageNews.php?id=3621141&headline=HPQ;DKNG;EDIT;RENT;MRK;RH;FLGT;WBA;AMAT;ROST;TJX;PNW;DPZ;AMZN;INSM-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180793927","content_text":"Top 5 Upgrades:JPMorgan analyst Lisa Gill upgraded Walgreens Boots Alliance(WBA) to Overweight from Neutral with a $42 price target. The company has \"significantly invested in its transformational consumer-centric healthcare strategy,\" the centerpiece of which is the launch of Walgreens Healthcare, Gill tells investors.Summit Insights analyst Kinngai Chan upgraded Applied Materials(AMAT) to Buy from Hold post the October quarter results. The analyst now believes the 2023 wafer dab spending cuts are priced into the stock.Gordon Haskett analyst Chuck Grom upgraded Ross Stores(ROST) to Buy from Hold with a $130 price target. He had turned incrementally more positive on the off-price retail space last week when he'd upgraded TJX (TJX) to Buy, but the results from Ross and across the space with over 10 companies under coverage reporting Q3 results this week lead him to see more \"evidence\" that middle-income shoppers would begin to trade down into the off-price space.Guggenheim analyst Shahriar Pourreza upgraded Pinnacle West(PNW) to Neutral from Sell with a price target of $70, up from $54. The regulatory construct in Arizona has improved following the election loss of Commissioner Sandra Kennedy and the victories of two Republican commissioners, Pourreza tells investors.Northcoast analyst Jim Sanderson upgraded Domino's Pizza(DPZ) to Buy from Neutral with a $460 price target.Top 5 Downgrades:Credit Suisse analyst Shannon Cross downgraded HP Inc.(HPQ) to Neutral from Outperform with an unchanged price target of $33. The analyst believes the company's revenue and margins will be \"challenged near term\" by weakening consumer sentiment, pressure on selling prices as a result of lower demand and better supply, slower enterprise demand near term for PCs and printing as IT budgets prioritize hybrid cloud, security and software solutions, and macroeconomic uncertainty.Oppenheimer analyst Jay Olson downgraded Editas Medicine(EDIT) to Perform from Outperform with a price target of $12, down from $28. The downgrade follows the announcement that the Phase 1/2 BRILLIANCE trial of EDIT-101 for Leber congenital amaurosis 10 is pausing enrollment following preliminary efficacy data that showed only three of the 14 patients met the responder threshold of clinically meaningful improvement in best corrected visual acuity, Olson tells investors in a research note. Credit Suisse analyst Tiago Fauth also downgraded Editas Medicine to Neutral from Outperform with a price target of $13, down from $25, after removing the contribution from EDIT-101 and other ocular indications from his model following the company's update from the BRILLIANCE trial.Morgan Stanley analyst Lauren Schenk downgraded Rent The Runway(RENT) to Equal Weight from Overweight with a price target of $2.50, down from $10. Recent web traffic data suggests a \"meaningful October slowdown\" and a Q3 subscriber miss after an encouraging September, Schenk tells investors in a research note.Wedbush analyst Seth Basham downgraded RH(RH) to Neutral from Outperform with a price target of $270, down from $274. RH has been steadfast in protecting its brand without discounting, but this has contributed to mounting market share losses, Basham tells investors in a research note.Erste Group analyst Hans Engel downgraded Amazon.com(AMZN) to Hold from Buy. The \"outlook for earnings development has deteriorated in recent weeks,\" Engel tells investors.Top 5 Initiations:Piper Sandler analyst Matt Farrell initiated coverage of DraftKings(DKNG) with an Overweight rating and $21 price target. DraftKings is a leader in the online sports betting market with a growing presence in internet gaming, which combined represent an $80B total addressable market between the United States and Canada, Farrell tells investors in a research note.Credit Suisse analyst Trung Huynh initiated coverage of Merck(MRK) with an Outperform rating and $120 price target, calling it one of his two top ideas based on a relative basis among the U.S. large-cap biopharma peer group. He sees Merck having \"low-risk and high short-term growth\" as he sees Keytruda growing at over 20% year-over-year, giving the company \"ample time\" to fill its loss-of-exclusivity cliff by end-2028.Raymond James analyst Andrew Cooper initiated coverage of Fulgent Genetics(FLGT) with an Outperform rating and $45 price target. The company capitalized on COVID-19 testing capabilities and has now deployed part of its \"substantial cash hoard\" to emerge from the pandemic with the full breadth of oncology testing capabilities, Cooper tells investors in a research note.BofA analyst Jason Zemansky initiated coverage of Insmed(INSM) with a Buy rating and $39 price target. The company's differentiated pipeline and strong underlying fundamentals place it apart from its peers, presenting a \"compelling\" risk-reward, the analyst tells investors in a research note.Morgan Stanley analyst Alex Straton assumed coverage of Ross Stores with an Overweight rating with a price target of $127, up from $119, following the company's Q3 report. The magnitude of the Q3 beat \"surprised to the upside\" and revenue re-acceleration \"makes for a compelling set-up\" into Q4 and 2023, said Straton, who thinks \"things only get better from here.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124853891,"gmtCreate":1624759502613,"gmtModify":1703844543178,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like pls","listText":"Comment and like pls","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/124853891","repostId":"2146070550","repostType":4,"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126779446,"gmtCreate":1624586273985,"gmtModify":1703841025806,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/126779446","repostId":"1144285047","repostType":4,"repost":{"id":"1144285047","pubTimestamp":1624586033,"share":"https://www.laohu8.com/m/news/1144285047?lang=&edition=full","pubTime":"2021-06-25 09:53","market":"us","language":"en","title":"Oil Set for Weekly Gain as Focus Turns to Upcoming OPEC+ Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1144285047","media":"Bloomberg","summary":"(Bloomberg) -- Oil is heading for a fifth weekly advance, the longest winning streak since December,","content":"<p>(Bloomberg) -- Oil is heading for a fifth weekly advance, the longest winning streak since December, as stockpiles shrink and the market tightens ahead of an OPEC+ meeting that will consider pumping more crude.</p>\n<p>Front-month futures in New York are up more than 2% this week and global benchmark Brent is at the highest level since October 2018. The alliance, led by Saudi Arabia and Russia, are set to meet July 1 and the group is widely expected to revive more output in August, according to a Bloomberg survey. Delegates from the coalition say discussions are already underway.</p>\n<p>The rebound in fuel consumption in key regions including the U.S. and Europe is rapidly draining stockpiles, with some flagging the possibility of benchmark Brent crude hitting $100 a barrel again. The prospect of an imminent surge of Iranian oil is also diminishing as talks to revive a nuclear deal drag on.</p>\n<p>The prompt timespread for Brent was 75 cents in backwardation -- where near-dated contracts are more expensive than later-dated ones. The bullish structure has eased from 85 cents at the start of the week.</p>\n<p>Russia is considering making a proposal that OPEC+ boost output and delegates say a hike is being informally discussed. The average gain forecast by analysts was for about 550,000 barrels a day -- barely a quarter of the global supply deficit that the alliance anticipates during August.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil Set for Weekly Gain as Focus Turns to Upcoming OPEC+ Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil Set for Weekly Gain as Focus Turns to Upcoming OPEC+ Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/oil-set-weekly-gain-focus-233523836.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Oil is heading for a fifth weekly advance, the longest winning streak since December, as stockpiles shrink and the market tightens ahead of an OPEC+ meeting that will consider pumping ...</p>\n\n<a href=\"https://finance.yahoo.com/news/oil-set-weekly-gain-focus-233523836.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/oil-set-weekly-gain-focus-233523836.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144285047","content_text":"(Bloomberg) -- Oil is heading for a fifth weekly advance, the longest winning streak since December, as stockpiles shrink and the market tightens ahead of an OPEC+ meeting that will consider pumping more crude.\nFront-month futures in New York are up more than 2% this week and global benchmark Brent is at the highest level since October 2018. The alliance, led by Saudi Arabia and Russia, are set to meet July 1 and the group is widely expected to revive more output in August, according to a Bloomberg survey. Delegates from the coalition say discussions are already underway.\nThe rebound in fuel consumption in key regions including the U.S. and Europe is rapidly draining stockpiles, with some flagging the possibility of benchmark Brent crude hitting $100 a barrel again. The prospect of an imminent surge of Iranian oil is also diminishing as talks to revive a nuclear deal drag on.\nThe prompt timespread for Brent was 75 cents in backwardation -- where near-dated contracts are more expensive than later-dated ones. The bullish structure has eased from 85 cents at the start of the week.\nRussia is considering making a proposal that OPEC+ boost output and delegates say a hike is being informally discussed. The average gain forecast by analysts was for about 550,000 barrels a day -- barely a quarter of the global supply deficit that the alliance anticipates during August.","news_type":1},"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128327954,"gmtCreate":1624502778478,"gmtModify":1703838582425,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like&nbsp;","listText":"Comment and like&nbsp;","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/128327954","repostId":"1105753491","repostType":4,"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125679385,"gmtCreate":1624673163447,"gmtModify":1703843302817,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hope it breaks 700 again&nbsp;","listText":"Hope it breaks 700 again&nbsp;","text":"Hope it breaks 700 again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/125679385","repostId":"1100072036","repostType":4,"repost":{"id":"1100072036","pubTimestamp":1624669285,"share":"https://www.laohu8.com/m/news/1100072036?lang=&edition=full","pubTime":"2021-06-26 09:01","market":"us","language":"en","title":"Tesla Stock Has Been on Fire This Week. Here Are 4 Reasons.","url":"https://stock-news.laohu8.com/highlight/detail?id=1100072036","media":"Barrons","summary":"Stock in electric-vehicle pioneer Tesla is on fire for seemingly no reason.There haven’t been any big,splashy upgrades that can explain the recent run. Shares have jumped almost 8% for the week and are on pace for their best week since April.Investors, rightly so, are wondering what’s going on. We found four reasons, outlined below.Many electric-vehicle stocks have been on a winning streak lately, beyond just Tesla. Coming into the week, shares of Chinese EV maker NIO were up 17% for the month.X","content":"<p>Stock in electric-vehicle pioneer&nbsp;Tesla&nbsp;is&nbsp;on fire&nbsp;for seemingly no reason.</p>\n<p>There haven’t been any big,splashy&nbsp;upgrades that can explain the recent run. Shares have jumped almost 8% for the week and are on pace for their best week since April.</p>\n<p>Investors, rightly so, are wondering what’s going on. We found four reasons, outlined below.</p>\n<p><b>Taking Cues From China</b></p>\n<p>Many electric-vehicle stocks have been on a winning streak lately, beyond just Tesla. Coming into the week, shares of Chinese EV maker&nbsp;NIO(NIO) were up 17% for the month.XPeng(XPEV) and&nbsp;Li Auto(LI) had gained 31% and 36%, respectively.</p>\n<p>Tesla, on the other hand, was down for the month of June coming into this week. But China is the world’s largest market for EVs, so when things are going well there, it bodes well for Tesla. It looks like some of the Chinese EV maker stocks’ shine has finally rubbed off on Tesla.</p>\n<p><b>Delivery Optimism</b></p>\n<p>The second reason is about second-quarter deliveries, after&nbsp;perceived weakness&nbsp;in Chinese delivery numbers. More recently, however, several&nbsp;reports&nbsp;have been popping up about Tesla working hard to deliver vehicles into the end of this month.</p>\n<p>“After a disaster start to the quarter for Tesla in China, the Street is reading the tea leaves as bullish for the month of June with momentum into [the second half],” Wedbush analyst&nbsp;Dan Ivestells&nbsp;Barron’s. He believes 900,000 deliveries is still possible for 2021. Wall Street is modeling about 825,000. Tesla delivered about 500,000 cars in 2020.</p>\n<p><b>Green Tidal Wave</b></p>\n<p>Ives has also written about a “green tidal wave” coming from the White House. President Joe Biden wants part of any infrastructure bill to include purchase incentives for EVs as well as charging infrastructure. A bill isn’t ready, but&nbsp;progress&nbsp;was made in Washington this week.</p>\n<p><b>Musk Tweeting, Again</b></p>\n<p>No search for the reason behind moves in Tesla stock would be complete without looking at CEO Elon Musk ‘s&nbsp;Twitter (TWTR) feed. He tweeted Friday that the updated full self-driving, or FSD, software and subscription pricing could roll out in as soon as a week.</p>\n<p>Tesla plans to offer its highest level of&nbsp;driver assistance, called full self-driving or FSD, on a subscription basis. It’s a new era for car companies, which don’t typically get to realize recurring revenue like software providers. Bulls have been waiting quite some time for the FSD subscription to arrive.</p>\n<p><b>What’s Next</b></p>\n<p>Next up for Tesla investors, after any FSD release, will be second-quarter delivery numbers and then earnings. Those data points come in July.</p>\n<p>Year to date, Tesla stock is still down about 4.8%, trailing behind comparable gains of the&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Has Been on Fire This Week. Here Are 4 Reasons.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Has Been on Fire This Week. Here Are 4 Reasons.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 09:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-gains-ev-elon-musk-51624638974?mod=hp_DAY_0><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock in electric-vehicle pioneer Tesla is on fire for seemingly no reason.\nThere haven’t been any big,splashy upgrades that can explain the recent run. Shares have jumped almost 8% for the week and ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-gains-ev-elon-musk-51624638974?mod=hp_DAY_0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-gains-ev-elon-musk-51624638974?mod=hp_DAY_0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100072036","content_text":"Stock in electric-vehicle pioneer Tesla is on fire for seemingly no reason.\nThere haven’t been any big,splashy upgrades that can explain the recent run. Shares have jumped almost 8% for the week and are on pace for their best week since April.\nInvestors, rightly so, are wondering what’s going on. We found four reasons, outlined below.\nTaking Cues From China\nMany electric-vehicle stocks have been on a winning streak lately, beyond just Tesla. Coming into the week, shares of Chinese EV maker NIO(NIO) were up 17% for the month.XPeng(XPEV) and Li Auto(LI) had gained 31% and 36%, respectively.\nTesla, on the other hand, was down for the month of June coming into this week. But China is the world’s largest market for EVs, so when things are going well there, it bodes well for Tesla. It looks like some of the Chinese EV maker stocks’ shine has finally rubbed off on Tesla.\nDelivery Optimism\nThe second reason is about second-quarter deliveries, after perceived weakness in Chinese delivery numbers. More recently, however, several reports have been popping up about Tesla working hard to deliver vehicles into the end of this month.\n“After a disaster start to the quarter for Tesla in China, the Street is reading the tea leaves as bullish for the month of June with momentum into [the second half],” Wedbush analyst Dan Ivestells Barron’s. He believes 900,000 deliveries is still possible for 2021. Wall Street is modeling about 825,000. Tesla delivered about 500,000 cars in 2020.\nGreen Tidal Wave\nIves has also written about a “green tidal wave” coming from the White House. President Joe Biden wants part of any infrastructure bill to include purchase incentives for EVs as well as charging infrastructure. A bill isn’t ready, but progress was made in Washington this week.\nMusk Tweeting, Again\nNo search for the reason behind moves in Tesla stock would be complete without looking at CEO Elon Musk ‘s Twitter (TWTR) feed. He tweeted Friday that the updated full self-driving, or FSD, software and subscription pricing could roll out in as soon as a week.\nTesla plans to offer its highest level of driver assistance, called full self-driving or FSD, on a subscription basis. It’s a new era for car companies, which don’t typically get to realize recurring revenue like software providers. Bulls have been waiting quite some time for the FSD subscription to arrive.\nWhat’s Next\nNext up for Tesla investors, after any FSD release, will be second-quarter delivery numbers and then earnings. Those data points come in July.\nYear to date, Tesla stock is still down about 4.8%, trailing behind comparable gains of the S&P 500 and Dow Jones Industrial Average.","news_type":1},"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167051094,"gmtCreate":1624240353718,"gmtModify":1703831263560,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/167051094","repostId":"1182485162","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123801467,"gmtCreate":1624414190859,"gmtModify":1703835946864,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/123801467","repostId":"1115637073","repostType":4,"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120678623,"gmtCreate":1624323165762,"gmtModify":1703833392488,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120678623","repostId":"2145352630","repostType":4,"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}